Clinical Trial Results:
Estudio de extensión abierto, multicéntrico, de fase II, de 54 semanas de duración, para evaluar la eficacia, seguridad y tolerabilidad de ACZ885 (anticuerpo monoclonal anti-interleuquina-1β) en pacientes con artritis reumatoide.
Summary
|
|
EudraCT number |
2007-001665-15 |
Trial protocol |
ES DE BE IT NL |
Global completion date |
13 Aug 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
21 Oct 2021
|
First version publication date |
14 Sep 2016
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
CACZ885A2211.CTR.16Aug2016 Full results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.